PHI with Hepatic veno-occlusive disease
How does this condition affect your private health insurance?
Venöse okklusive Leberkrankheit (VOLD), also known as Sinusoidal Obstruction Syndrome (SOS), is a serious condition characterized by non-thrombotic obliteration of small intrahepatic veins and liver sinusoids. This obstruction leads to impaired liver blood flow, causing hepatomegaly, ascites, jaundice, and weight gain. It often occurs as a complication of high-dose chemotherapy, especially in preparation for hematopoietic stem cell transplantation, or exposure to certain toxins or herbal remedies. The severity can range from mild and self-limiting to severe, life-threatening liver failure, requiring intensive medical management. Early diagnosis and intervention are crucial for improving outcomes.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Acute onset, typically days to weeks post-exposure, often lasting several weeks.
Duration of Illness (Lifetime)
Can be a one-time acute event resolving completely, or lead to chronic liver damage, fibrosis, and portal hypertension in severe or persistent cases.
Cost of Treatment (Initial)
Very high, often involving intensive care unit stays, specialized medications (e.g., defibrotide), and extensive diagnostic monitoring.
Cost of Treatment (Lifetime)
Can be extremely high, especially if chronic complications develop, requiring ongoing specialist care, management of portal hypertension, or even liver transplantation in refractory cases.
Mortality Rate
Significant, ranging from 5-50% depending on severity and risk factors, with severe forms having a higher mortality rate.
Risk of Secondary Damages
High, including liver failure, renal dysfunction, pulmonary hypertension, ascites, portal hypertension, and chronic liver disease.
Probability of Full Recovery
Moderate to good in mild cases (up to 70-80%), but much lower (e.g., less than 30%) in severe forms, often with residual liver dysfunction.
Underlying Disease Risk
High, as VOLD/SOS is frequently a complication of pre-existing conditions treated with therapies like hematopoietic stem cell transplantation (for various cancers like leukemia, lymphoma, multiple myeloma), or exposure to hepatotoxic agents.